TA
Tiedemann Advisors’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $2.85M | Buy |
5,308
+4,739
| +833% | +$2.55M | 0.12% | 65 |
|
2023
Q2 | $267K | Buy |
+569
| New | +$267K | 0.01% | 213 |
|
2021
Q3 | – | Sell |
-7,092
| Closed | -$1.63M | – | 334 |
|
2021
Q2 | $1.63M | Sell |
7,092
-544
| -7% | -$125K | 0.07% | 125 |
|
2021
Q1 | $1.43M | Buy |
7,636
+138
| +2% | +$25.8K | 0.06% | 129 |
|
2020
Q4 | $1.27M | Buy |
7,498
+82
| +1% | +$13.9K | 0.06% | 130 |
|
2020
Q3 | $1.1M | Sell |
7,416
-2
| -0% | -$296 | 0.05% | 167 |
|
2020
Q2 | $1.22M | Sell |
7,418
-5
| -0.1% | -$820 | 0.06% | 153 |
|
2020
Q1 | $1.03M | Buy |
7,423
+712
| +11% | +$98.8K | 0.07% | 151 |
|
2019
Q4 | $882K | Sell |
6,711
-1,062
| -14% | -$140K | 0.04% | 173 |
|
2019
Q3 | $871K | Sell |
7,773
-65
| -0.8% | -$7.28K | 0.04% | 184 |
|
2019
Q2 | $867K | Sell |
7,838
-2,700
| -26% | -$299K | 0.04% | 164 |
|
2019
Q1 | $1.37M | Buy |
10,538
+167
| +2% | +$21.7K | 0.06% | 178 |
|
2018
Q4 | $1.2M | Buy |
10,371
+7,808
| +305% | +$904K | 0.06% | 185 |
|
2018
Q3 | $275K | Sell |
2,563
-97
| -4% | -$10.4K | 0.02% | 266 |
|
2018
Q2 | $228K | Buy |
+2,660
| New | +$228K | 0.01% | 278 |
|
2017
Q3 | – | Sell |
-9,188
| Closed | -$756K | – | 408 |
|
2017
Q2 | $756K | Buy |
9,188
+1,664
| +22% | +$137K | 0.06% | 255 |
|
2017
Q1 | $633K | Buy |
+7,524
| New | +$633K | 0.05% | 238 |
|